Severe hemodynamic depression after carotid artery stenting: The problem overcome with a transvenous temporary

Masako Fujii1, Takeshi Satow1, Hiroshi Kodama2

  • 1Department of Neurosurgery, Nagahama City Hospital, Nagahama, Shiga, Japan.

Insights

Transvenous temporary cardiac pacing (TTCP) can prevent hemodynamic depression after carotid angioplasty stenting (CAS). Smoking and calcified plaque are key predictors, guiding patient selection for TTCP before CAS.

Area of Science:

  • Cardiovascular Interventions
  • Neurosurgery
  • Critical Care Medicine

Background:

  • Carotid angioplasty stenting (CAS) carries risks, including perioperative hemodynamic depression.
  • Transvenous temporary cardiac pacing (TTCP) is a potential preventative measure against circulatory failure during CAS.
  • Identifying predictors of hemodynamic depression is crucial for selecting patients who may benefit from preoperative TTCP.

Observation:

  • An 84-year-old male with asymptomatic severe left carotid stenosis underwent CAS.
  • A TTCP was proactively implanted due to anticipated hemodynamic depression risk.
  • Post-CAS, the patient experienced severe hypotension and cardiac arrest, successfully managed with TTCP activation and vasopressors.

Findings:

  • A literature review identified smoking (OR 1.68) and severely calcified plaque (OR 3.70) as significant predictors of perioperative hemodynamic depression after CAS.
  • These factors indicate an increased risk of adverse hemodynamic events during or after the procedure.

Implications:

  • TTCP is recommended for patients undergoing CAS, especially those with a history of smoking or severely calcified plaques.
  • Proactive TTCP implantation can mitigate severe complications and improve patient outcomes following CAS.
  • This strategy enhances patient safety in high-risk CAS procedures.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
155
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
77
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
321
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
95
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
63
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
104